BMRA Valuation
Biomerica Inc
$
3.440
- Overview
- Forecast
- Valuation
- Earnings
BMRA Relative Valuation
BMRA's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, BMRA is overvalued; if below, it's undervalued.
Historical Valuation
Biomerica Inc (BMRA) is now in the Undervalued zone, suggesting that its current forward PS ratio of 0.37 is considered Undervalued compared with the five-year average of 9.11. The fair price of Biomerica Inc (BMRA) is between 18.62 to 59.09 according to relative valuation methord. Compared to the current price of 3.44 USD , Biomerica Inc is Undervalued By 81.52%.
Relative Value
Fair Zone
18.62-59.09
Current Price：3.44
81.52%
Undervalued
1.21
PE
1Y
3Y
5Y
Trailing
Forward
0.00
EV/EBITDA
Biomerica Inc. (BMRA) has a current EV/EBITDA of 0.00. The 5-year average EV/EBITDA is 3.21. The thresholds are as follows: Strongly Undervalued below -18.51, Undervalued between -18.51 and -7.65, Fairly Valued between 14.07 and -7.65, Overvalued between 14.07 and 24.93, and Strongly Overvalued above 24.93. The current Forward EV/EBITDA of 0.00 falls within the Historic Trend Line -Fairly Valued range.
1.48
EV/EBIT
Biomerica Inc. (BMRA) has a current EV/EBIT of 1.48. The 5-year average EV/EBIT is 9.67. The thresholds are as follows: Strongly Undervalued below -62.04, Undervalued between -62.04 and -26.18, Fairly Valued between 45.52 and -26.18, Overvalued between 45.52 and 81.37, and Strongly Overvalued above 81.37. The current Forward EV/EBIT of 1.48 falls within the Historic Trend Line -Fairly Valued range.
0.37
PS
Biomerica Inc. (BMRA) has a current PS of 0.37. The 5-year average PS is 3.14. The thresholds are as follows: Strongly Undervalued below -2.35, Undervalued between -2.35 and 0.39, Fairly Valued between 5.88 and 0.39, Overvalued between 5.88 and 8.62, and Strongly Overvalued above 8.62. The current Forward PS of 0.37 falls within the Undervalued range.
0.00
P/OCF
Biomerica Inc. (BMRA) has a current P/OCF of 0.00. The 5-year average P/OCF is -0.47. The thresholds are as follows: Strongly Undervalued below -17.22, Undervalued between -17.22 and -8.85, Fairly Valued between 7.90 and -8.85, Overvalued between 7.90 and 16.27, and Strongly Overvalued above 16.27. The current Forward P/OCF of 0.00 falls within the Historic Trend Line -Fairly Valued range.
0.00
P/FCF
Biomerica Inc. (BMRA) has a current P/FCF of 0.00. The 5-year average P/FCF is -19.63. The thresholds are as follows: Strongly Undervalued below -248.97, Undervalued between -248.97 and -134.30, Fairly Valued between 95.04 and -134.30, Overvalued between 95.04 and 209.72, and Strongly Overvalued above 209.72. The current Forward P/FCF of 0.00 falls within the Historic Trend Line -Fairly Valued range.
Biomerica Inc (BMRA) has a current Price-to-Book (P/B) ratio of 1.73. Compared to its 3-year average P/B ratio of 2.60 , the current P/B ratio is approximately -33.51% higher. Relative to its 5-year average P/B ratio of 3.94, the current P/B ratio is about -56.07% higher. Biomerica Inc (BMRA) has a Forward Free Cash Flow (FCF) yield of approximately -42.68%. Compared to its 3-year average FCF yield of -41.54%, the current FCF yield is approximately 2.73% lower. Relative to its 5-year average FCF yield of -27.20% , the current FCF yield is about 56.90% lower.
1.73
P/B
Median3y
2.60
Median5y
3.94
-42.68
FCF Yield
Median3y
-41.54
Median5y
-27.20
Competitors Valuation Multiple
The average P/S ratio for BMRA's competitors is 7.45, providing a benchmark for relative valuation. Biomerica Inc Corp (BMRA) exhibits a P/S ratio of 0.37, which is -94.98% above the industry average. Given its robust revenue growth of 10.03%, this premium appears unsustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
Performance Decomposition
1Y
3Y
5Y
Market capitalization of BMRA increased by 29.94% over the past 1 year. The primary factor behind the change was an decrease in P/E Change from -1.07 to -1.76.
The secondary factor is the Revenue Growth, contributed 10.03%to the performance.
Overall, the performance of BMRA in the past 1 year is driven by P/E Change. Which is more unsustainable.
People Also Watch
FAQ
Is Biomerica Inc (BMRA) currently overvalued or undervalued?
Biomerica Inc (BMRA) is now in the Undervalued zone, suggesting that its current forward PS ratio of 0.37 is considered Undervalued compared with the five-year average of 9.11. The fair price of Biomerica Inc (BMRA) is between 18.62 to 59.09 according to relative valuation methord. Compared to the current price of 3.44 USD , Biomerica Inc is Undervalued By 81.52% .
What is Biomerica Inc (BMRA) fair value?
How does BMRA's valuation metrics compare to the industry average?
What is the current P/B ratio for Biomerica Inc (BMRA) as of Jul 30 2025?
What is the current FCF Yield for Biomerica Inc (BMRA) as of Jul 30 2025?
What is the current Forward P/E ratio for Biomerica Inc (BMRA) as of Jul 30 2025?